The factor IX γ-carboxyglutamic acid (Gla) domain is involved in interactions between factor IX and factor XIa

被引:40
|
作者
Aktimur, A
Gabriel, MA
Gailani, D
Toomey, JR
机构
[1] Vanderbilt Univ, Div Hematol Oncol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA
[4] GlaxoSmithKline, Cardiovasc & Urogenital Dis Ctr Excellence, King Of Prussia, PA 19406 USA
关键词
D O I
10.1074/jbc.M212748200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During hemostasis, factor IX is activated to factor IXabeta by factor VIIa and factor XIa. The glutamic acid-rich gamma-carboxyglutamic acid (Gla) domain of factor IX is involved in phospholipid binding and is required for activation by factor VIIa. In contrast, activation by factor XIa is not phospholipid-dependent, raising questions about the importance of the Gla for this reaction. We examined binding of factors IX and IXabeta to factor XIa by surface plasmon resonance. Plasma factors IX and IXabeta bind to factor XIa with K-d values of 120 +/- 11 nm and 110 +/- 8 nm, respectively. Recombinant factor IX bound to factor XIa with a Kd of 107 nm, whereas factor IX with a factor VII Gla domain (rFIX/VII-Gla) and factor IX expressed in the presence of warfarin (rFIX-desgamma) did not bind. An anti-factor IX Gla monoclonal antibody was a potent inhibitor of factor IX binding to factor XIa (K-i 34 nm) and activation by factor XIa (Ki 33 nm). In activated partial thromboplastin time clotting assays, the specific activities of plasma and recombinant factor IX were comparable (200 and 150 units/mg), whereas rFIX/VII-Gla activity was low (<2 units/mg). In contrast, recombinant factor IXabeta and activated rFIX/VIIa-Gla had similar activities (80 and 60% of plasma factor IXabeta), indicating that both proteases activate factor X and that the poor activity of zymogen rFIX/VII-Gla was caused by a specific defect in activation by factor XIa. The data demonstrate that factor XIa binds with comparable affinity to factors IX and IXabeta and that the interactions are dependent on the factor IX Gla domain.
引用
收藏
页码:7981 / 7987
页数:7
相关论文
共 50 条
  • [1] The factor IX Gla-domain is required for factor XI activation by factor XIa.
    Toomey, JR
    Aktimur, A
    Gabriel, MA
    Gailani, D
    BLOOD, 2002, 100 (11) : 264A - 264A
  • [2] Exosite Interactions in Factor IX Activation by Factor XIa
    Geng, Yipeng
    Verhamme, Ingrid M.
    Smith, Stephen B.
    Messer, Amanda S.
    Sun, Mao-fu
    Bajaj, S. Paul
    Gailani, David
    BLOOD, 2011, 118 (21) : 973 - 973
  • [3] Activation of factor IX by factor XIa
    Gailani, D
    TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (05) : 198 - 204
  • [4] BIOCHEMICAL STUDIES ON INTERACTION BETWEEN FACTOR XIA AND FACTOR IX
    KINGDON, HS
    LUNDBLAD, RL
    FEDERATION PROCEEDINGS, 1973, 32 (03) : 273 - &
  • [5] A model for binding of factor IX to the factor XIa apple 3 domain
    Gailani, D.
    Geng, Y.
    Verhamme, I. M.
    Sun, M. F.
    Bajaj, P.
    Emsley, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 127 - 127
  • [6] Factor XIa dimer in the activation of factor IX
    Sinha, D
    Marcinkiewicz, M
    Lear, JD
    Walsh, PN
    BIOCHEMISTRY, 2005, 44 (30) : 10416 - 10422
  • [7] The mechanism underlying activation of factor IX by factor XIa
    Gailani, David
    Geng, Yipeng
    Verhamme, Ingrid
    Sun, Mao-fu
    Bajaj, S. Paul
    Messer, Amanda
    Emsley, Jonas
    THROMBOSIS RESEARCH, 2014, 133 : S48 - S51
  • [8] Exosite-mediated substrate recognition of factor IX by factor XIa - The factor XIa heavy chain is required for initial recognition of factor IX
    Ogawa, T
    Verhamme, IM
    Sun, MF
    Bock, PE
    Gailani, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (25) : 23523 - 23530
  • [9] Specificity of factor IX and factor X Gla aminophospholipids
    Satta, N
    Huang, QL
    Neuenschwander, P
    Morrissey, JH
    THROMBOSIS AND HAEMOSTASIS, 1999, : 480 - 481
  • [10] Xray crystallographic structure of the Factor IX Gla domain bound to an inhibitory anti-Factor IX antibody.
    Huang, MD
    Furie, BC
    Jacobs, M
    Furie, B
    BLOOD, 2002, 100 (11) : 17A - 17A